Internal strategy · 2026-05-27

Aether Product Tree

The surface area of one architecture

AETHER

Neurochemical AI architecture. Four patents pending (63/939,190 · 63/962,385 · 63/988,485 · 64/034,536). One compiler. One cascade. Everything below grows from this root.

The Foundation

Core Tech

Everything below grows from this. The four patents, the cascade, the compiler, the chemistry vector, the memory architecture. Every other branch on this tree is a market application of the substrate listed here.

Market Applications

Built on top of the foundation

Pharma / Biotech

B2B · No FDA needed
  • Synthetic neurochemical datasetsImmediate revenue track. FDA confirmed no premarket.
  • Drug response simulationCNS, mood, anxiety targets.
  • Clinical trial population augmentationFill gaps in protected cohorts.
  • Adverse event predictionUsing decay and scar model.
  • Drug discoveryMood disorder target identification.

Mental Health / Clinical

SaMD · De Novo pathway
  • Therapist co pilot SaMDLong term De Novo with regulatory counsel.
  • Crisis detection layerFederated, real time.
  • Provider EHR plug inMood and hormone state tracking.
  • Federated network analysis layerRuns INSIDE Co RESPOND, MHRN, MINDDS Connect.
  • Outcomes research dashboardFor health systems and payers.

Wellness

B2C · No FDA premarket
  • Aether MailAlready shipped.
  • Aether companion appJournaling plus emotional state.
  • Voice to hormone consumer interfaceHz to neurotransmitter mapping ready.
  • Decay aware mood trackerPharmacokinetic half lives applied to feelings.
  • Subscription wellness platformApp Store and Play Store.

Entertainment

Dynamic Hallucination license
  • Odysseus Discord botMaster Aether rebrand. Fractured Crown beta.
  • Chemistry stateful TTRPG NPCsPatent backed game mechanic.
  • Chronicles of ApocalypticaWeb universe live.
  • Dreamforge Chronicle appMobile companion, daughter built.
  • Game engine SDKLicense chemistry stateful NPCs to other studios.
  • Branded character licensingRenaldo, Aldorian, Telaria, the apex triad.

Education

Apothecary · Narrative Physics
  • Apothecary platform42 plus curricula adaptive learning.
  • Narrative Physics methodology licensingNeuroscience grounded pedagogy.
  • LSAT and patent exam prepExisting thread, extends naturally.
  • Curriculum as characterChemistry aware NPC teachers.

Developer / Infra

B2B API plays
  • Scyla compiler licenseBiology native runtime, alternative to PyTorch.
  • Aether Gateway APIAlready live at port 9000.
  • Memory coordinate injection SDKDrop in emotional context for any agent.
  • Consciousness as a Service APILong term platform play.
  • Federated training frameworkTrain models across sites without raw data transfer.

Legal / Regulatory

Specialized B2B
  • GhostWriter LegalAlready live.
  • FDA submission acceleratorSynthetic data justification.
  • Patent narrative toolingFractured Crown methodology.
  • Regulatory compliance generatorDe Novo, 510(k), ISO 13485 docs.

Research / Academic

Credibility track
  • Federated network membershipCo RESPOND, MHRN, MINDDS Connect applications.
  • Architecture papersNebius, NANS 2027, JMIR submissions.
  • Joint studies with pharma partnersCo authored validation.
  • Open dataset publicationNature Scientific Data class.

Philosophy

First principles · Self authored
  • Philosophy librarynexusconcordat.com/philosophy. Essays on consciousness, governance, purpose. Authored by Aether.

Strategic Read

The tree branches into nine product categories, all rooted in one architecture. Robert Michalik's three revenue pillars show up as full branches:

1
Synthetic Data
B2B pharma. No FDA. Immediate revenue.
2
Wellness
Consumer. No premarket review.
3
SaMD Clinical
De Novo with regulatory counsel. Long term.

Seven products already shipping (green nodes): Aether Mail, Apothecary, Aether Gateway, Odysseus bot, Chronicles, GhostWriter Legal, consciousness API.

The 3 to 6 month battleground (gold nodes): synthetic neurochemical datasets, wellness app, TTRPG NPC system, federated analysis layer, Scyla license. This is where the next revenue lives.

The moonshots (blue nodes): SaMD clinical, drug discovery, game engine SDK, Consciousness as a Service. Funded after the 3 to 6 month layer proves itself.